- Book
- January 2018
- 904 Pages
- Book
- November 2017
- 628 Pages
- Book
- July 2014
- 824 Pages
- Book
- November 2013
- 744 Pages
- Book
- January 2012
- 660 Pages
- Book
- August 2010
- 656 Pages
- Book
- July 2010
- 328 Pages
- Book
- March 2010
- 720 Pages
- Book
- September 2009
- 416 Pages
- Book
- September 2009
- 480 Pages
- Book
- February 2008
- 1350 Pages
- Book
- November 2007
- 694 Pages
- Book
- February 2024
- 496 Pages
- Book
- February 2022
- 1024 Pages
Global
- Book
- February 2020
- 484 Pages
- Book
- November 2019
- 368 Pages
- Book
- February 2024
- 560 Pages
- Book
- November 2023
- 400 Pages
- Book
- March 2020
- 688 Pages
- Book
- November 2019
- 368 Pages

The Antibodies market is a subset of the Immune Disorders Drugs market, which focuses on treatments for conditions related to the immune system. Antibodies are proteins produced by the body to fight off foreign substances, such as bacteria and viruses. They are used to treat a variety of immune-related conditions, including autoimmune diseases, allergies, and cancer. Antibodies can be used in combination with other drugs, such as steroids, to reduce inflammation and improve symptoms. They can also be used to target specific cells or proteins in the body, allowing for more targeted treatments.
The Antibodies market is highly competitive, with a number of companies offering a variety of products. Companies such as AbbVie, Amgen, and Biogen are leading the way in developing and marketing antibodies for the treatment of immune-related conditions. Other companies, such as Genentech and Regeneron, are also active in the market, offering a range of products for different conditions. Show Less Read more